Pathogenesis of IgA nephropathy

Contributions to Nephrology

Volumn 157, Issue , 2007, Pages 1-7

  Tomino, Yasuhiko ^a,b  

^a JUNTENDO UNIVERSITY   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; CONFERENCE PAPER; DISEASE MODEL; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOLOGY; MAST CELL; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; GLOMERULONEPHRITIS, IGA; HUMANS; MAST CELLS;

EID: 34249085624     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/0000102280     Document Type: Conference Paper

References (14)

1. Imai H, Nakamoto Y, Asakura K, et al: Spontaneous glomerular IgA deposition in ddY mice: An animal model of IgA nephritis. Kidney Int 1985;27:756-761.
2. Tomino Y, Nakamura T, Ebihara I, et al: Altered steady-state of mRNA coding for extracellular matrices in renal tissues of ddY mice, an animal model for IgA nephropathy. J Clin Lab Anal 1991;5:106-113.
3. Yoshiki T, Mellors RC, Strand M, et al: The viral envelope glycoprotein of murine leukemia virus and the pathogenesis of immune complex glomerulonephritis of New Zealand mice. J Exp Med 1974;140:1011-1027.
4. Izui S, MaConahey PJ, Theofilopoulos AN, et al: Association of circulating retroviral gp70-anti-gp70 immune complexes with murine systemic lupus erythematosus. J Exp Med 1979;149:1099-1116.
5. Takeuchi E, Doi T, Shimada T, et al: Retroviral gp70 antigen in spontaneous mesangial glomerulonephritis of ddY mice. Kidney Int 1989;35:638-646.
6. Shimizu M, Tomino Y, Abe M, et al: Retroviral envelope glycoprotein(gp 70) is not a prerequisite for pathogenesis of primary immunoglobulin A nephropathy in ddY mice. Nephron 1992;62:328-331.
7. Suzuki H, Suzuki Y, Yamanaka T, et al: Genome-wide scan in a novel IgA nephropathy model identifies a susceptibility locus on murine chromosome 10, in a region syntenic to human IGAN1 on chromosome 6q22-23. J Am Soc Nephrol 2005;16:1289-1299.
8. Pagtaluman ME, Miller PL, Jumping-Eagle S, et al: Podocyte loss and progressive glomerular injury in type II diabetes. J Clin Invest 1997;99:342-348.
9. Asanuma K, Shirato I, Ishido K, et al: Selective modulation of the secretion of proteinases and their inhibitors by growth factors in cultured differentiated podocytes. Kidney Int 2002;62:822-831.
10. Hishiki T, Shirato I, Takahashi Y , et al: Podocyte injury predicts prognosis in patients with IgA nephropathy using a small amount of renal biopsy tissue. Kidney Blood Press Res 2001:24:99-104.
11. Irani AA, Schechter NM, Craig SS, et al: Two types of human mast cells that have distinct neutral protease compositions. Proc Natl Acad Sci USA 1986;83:4464-4468.
12. Kurusu A, Suzuki Y, Horikoshi S, et al: Relationship between mast cells in the tubulointerstitium and prognosis of patients with IgA nephropathy. Nephron 2001;89:391-397.
13. Chandrasekharan UM, Sanker S, Glynias MJ, et al: Angiotensin II-forming activity in a reconstructed ancestral chymase. Science 1996;271:502-505.
14. Caughey GH, Raymond WW, Wolters PJ, et al: Angiotensin II generation by mast cell alpha- and beta-chymases. Biochim Biophys Acta 2000;1480:245-257.